Severe Hypoglycemia Caused by a Giant Borderline Phyllodes Tumor of the Breast: A Case Report and Literature Review

Front Endocrinol (Lausanne). 2022 May 26:13:871998. doi: 10.3389/fendo.2022.871998. eCollection 2022.

Abstract

A case of hypoglycemic coma caused by a giant borderline phyllodes tumor of the breast has been described. The patient, a 63-year-old woman, was admitted with recurrent unconsciousness. She had a giant breast tumor with decreased blood glucose, insulin, and C-peptide. The patient's hypoglycemia resolved rapidly after resection of the breast tumor. Pathological examination indicated a borderline phyllodes tumor of the breast, and immunohistochemistry suggested high expression of insulin-like growth factor-2 (IGF-2) in the tumor tissue. A literature review is also included to summarize the clinical characteristics of such patients and to serve as a unique resource for clinical diagnosis and treatment of similar cases.

Keywords: breast; hypoglycemia; insulin-like growth factor-2; non-islet cell tumor hypoglycemia; phyllodes tumor.

Publication types

  • Case Reports
  • Systematic Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms* / complications
  • Breast Neoplasms* / metabolism
  • Breast Neoplasms* / surgery
  • C-Peptide
  • Female
  • Humans
  • Hypoglycemia* / etiology
  • Insulin
  • Middle Aged
  • Phyllodes Tumor* / complications
  • Phyllodes Tumor* / metabolism
  • Phyllodes Tumor* / surgery

Substances

  • C-Peptide
  • Insulin